J&J’s Ethicon completes first robot-assisted kidney stone removal with Monarch platform

The Monarch platform for robot-assisted urology procedures. [Image courtesy of Johnson & Johnson’s Ethicon]Ethicon, a Johnson & Johnson MedTech company, today announced the first robotic-assisted removal of kidney stones using the Monarch platform.

Auris Health, an Ethicon subsidiary, received FDA clearance for Monarch for endourological procedures in May 2022. The University of California, Irvine’s UCI Health used the Monarch platform for urology to complete the first procedure.

According to a news release, it’s the first successful robotically assisted, electromagnetic-guided percutaneous access and mini-percutaneous nephrolithotomy procedure. Ethicon said its study involves a collaboration with co-investigator Dr. Mihir Desai from the University of Southern California.

“This clinical study is the first in the world to research and demonstrate the potential for improved navigation, access, clearance and control in mini-PCNL proce…

Read more
  • 0

Ronovo Surgical unveils Carina surgical robot platform

The Carina surgical robot system. [Image courtesy of Ronovo Surgical]Ronovo Surgical announced today that it closed a new round of financing, bringing its total funds raised to more than $50 million since 2020.

Shanghai-based Ronovo develops broad, cross-specialty robotic-assisted surgery (RAS) technology. LongRiver Investments led the latest financing round. Existing investors Lilly Asia Ventures, Vivo Capital, Matrix Partners China and GGV Capital participated. CEC Capital acted as the exclusive financial advisor.

Ronovo said it now exits “stealth mode,” unveiling its inaugural Carina robotic platform. Carina, a modular system built on proprietary technology, enables configurable robotic assistance for laparoscopic surgeries across multiple specialties.

Add Ronovo to a host of companies, large and small, that are seeking to take on Intuitive in the soft-tissue robotic surgery space. (Here are 16 surgical robotics companies you need to know.) Read more

  • 0

Intuitive stock down amid next-gen robot disappointment

Intuitive Surgical (Nasdaq:ISRG) shares took a hit after an earnings call in which CEO Gary Guthart pushed back the timing of a potential next-gen surgical robotics multiport system.

“As we start this year, we do not currently expect a new multiport system launch in 2023,” Guthart said in a call with analysts this evening.

Later in the night, BTIG analysts released a note with the headline: “Multiport Head-Fake Tanks Shares Midway Through the Earnings Call; It’s Not What Many Wanted to Hear.”

ISRG shares were down more than 9% to $257.98 apiece after-hours.

“Shares tanked, and we’re scratching our heads a bit as we try to understand ISRG’s thinking. Some of the change in posture appears to be stemming from a dynamic regulatory environment (across multiple geographies), which may require clinical trials that push out clearances, but supply chain (and new component availability) also appears to be an i…

Read more
  • 0

Intuitive expects da Vinci procedures to increase at least 12% in 2023

The Da Vinci Xi robotic surgery system. Intuitive continues to dominate the space. [Image courtesy of Intuitive]Intuitive Surgical (Nasdaq:ISRG) today announced preliminary results for the fourth quarter and looked ahead to expected 2023 results.

The Sunnyvale, California-based surgical robot developer expects fourth-quarter revenue to total $1.66 billion. While that represents a 7% increase from the same period in 2021, it falls just shy of Wall Street expectations. Analysts projected revenues totaling $1.68 billion. The company expects full-year 2022 revenues of $6.22 billion for a 9% increase over the previous year.

Shares of ISRG dipped 4.3% at $259.70 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose 8.8%.

Worldwide procedures with the da Vinci surgical robot grew 18% compared to the fourth quarter of 2021. This occurred despite a COVID-19 res…

Read more
  • 0

Intuitive expects da Vinci procedures to increase at least 12% in 2023

The Da Vinci Xi robotic surgery system. Intuitive continues to dominate the space. [Image courtesy of Intuitive]Intuitive Surgical (Nasdaq:ISRG) today released preliminary Q4 results that included a slight revenue miss, though the company expects da Vinci surgical robot procedures to grow at least 12% this year.

The Sunnyvale, California-based surgical robot developer expects fourth-quarter revenue to total $1.66 billion. While that represents a 7% increase from the same period in 2021, it falls just shy of Wall Street expectations. Analysts projected revenues totaling $1.68 billion. The company expects full-year 2022 revenues of $6.22 billion for a 9% increase over the previous year.

Shares of ISRG dipped 4.3% at $259.70 apiece in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — rose 8.8%.

Worldwide procedures with the da Vinci surgical robot grew 18% compared …

Read more
  • 0

Asensus Surgical announces Senhance surgical robot placement in Japan

[Image from Asensus Surgical]Asensus Surgical (NYSE:ASXC) announced today that it entered into an agreement to lease a Senhance surgical robot to a Japanese hospital.

Kashiwa Kosei General Hospital (Kashiwa, Japan) agreed to lease the surgical robot system. It marks the second recent adoption of Senhance in Japan. In September, Saiseikai Shiga Hospital in Ritto, Japan, agreed to lease a surgical robot.

“We are pleased to be partnering with another impressive institution as we continue to see high adoption rates in one of the fastest growing regions for Asensus,” said Anthony Fernando, Asensus Surgical president and CEO. “The recently approved thoracic indication will be a great addition to the Kashiwa Kosei General Hospital’s surgery department.”

Senhance, a first-of-its-kind digital laparoscopic surgical robot, uses augmented intelligence to perform procedures through machine learning. It features surgical assurance through haptic feedback, eye-track…

Read more
  • 0

Medtronic enrolls first patients in Hugo surgical robot clinical trial

The Hugo robotic surgery system [Image from Medtronic]Medtronic (NYSE:MDT) announced today that it enrolled the first patient in its Expand URO U.S. clinical trial for the Hugo surgical robot.

Dr. Michael R. Abern at Duke University Hospital (Durham, North Carolina) performed the procedure. He used the Hugo robotic-assisted surgery (RAS) system for a robotic-assisted prostatectomy procedure.

“This is an exciting moment,” said Dr. Abern. “Robotic-assisted surgery provides many benefits within my specialty of urology, and I’m proud to have performed the first U.S. clinical trial case with the Medtronic Hugo RAS system.”

Medtronic intended for the use of Hugo in the study across a range of urologic surgical procedures. That includes radical prostatectomy, radical cystectomy, and nephrectomy (partial or radical) procedures at sites in the U.S.

The study, conducted pursuant to an FDA investigational device exemption (IDE), wi…

Read more
  • 0

Titan Medical wins new patent to expand surgical robot IP

The Enos surgical robot platform. [Image from Titan Medical]Titan Medical (Nasdaq:TMDI) announced today that the U.S. Patent and Trademark office (USPTO) issued a new patent for its surgical robot.

The USPTO issued patent No. 11,504,191, titled “Graphical User Interface for a Robotic Surgical System.” It generally covers a graphical user interface (GUI) overlay of a surgical workspace to track instrument movement.

According to Titan, the patent aims to enhance the surgeon’s user experience.

“The granting of this patent is a result of our strategic plan to independently build and protect a robust patent portfolio in robotic-assisted surgery, including around the Enos robotic single-access surgical system. Today’s news validates our commitment to the continuum of innovation in robotic-assisted surgery,” said Cary Vance, president and CEO of Titan. “Along with recent patent application filings, including some that have recently published, this patent dem…

Read more
  • 0

Moon Surgical wins first FDA 510(k) clearance for surgical robot

This screen grab from a Moon Surgical marketing video gives an idea of what the Maestro robotic surgery system looks like in action [Image courtesy of Moon Surgical]Moon Surgical announced today that it received FDA 510(k) clearance for its Maestro surgical robotics system.

Paris- and San Francisco-based Moon Surgical designed Maestro to support surgeons in soft tissue surgical procedures. Think of it as a robotic surgical assistant.

The small, adaptable system can integrate into existing clinical workflows. It features capabilities that bolster operating room efficiency and allow for alternative labor models, the company said.

In June, Moon Surgical completed a $31.3 million Series A fundraising. CEO Ann Osdoit said the company aims to make Maestro capable of use in any laparoscopy in any operating room. This could revolutionize minimally invasive surgery through collaborative and adaptive robotics.

Moon Surgical featured…

Read more
  • 0

FDA clears Neocis surgical robot for bone reduction

The Yomi surgical robot. [Image from Neocis]Neocis announced today that it received FDA 510(k) clearance for its Yomi surgical robot system for use in guided bone reduction.

This represents the second FDA clearance for Neocis this year, and its 14th in total.

Miami-based Neocis designed its Yomi surgical robot for dental surgery. It assists clinicians in the planning and operative phases of dental implant placement. For example, Yomi offers interactive digital planning software and physical guidance for surgical instrumentation.

The new indication for Yomi allows dental professionals to perform robot-guided alveoloplasty of the mandible and/or maxilla. This is commonly referred to as bone reduction, according to a news release.

A CT scan of the patient digitally plans the bone reduction and placement of implants. During the procedure, Yomi’s guide arm provides haptic feedback. This keeps the burr from deviating beyond …

Read more
  • 0

Titan Medical CEO sees ‘unique opportunity’ for Enos surgical robot in an increasingly crowded field

Titan Medical CEO Cary Vance [Photo from Vance’s LinkedIn page] Titan Medical CEO Cary Vance discusses the Enos robotic surgery platform, deals with Medtronic and supply chain silver linings.

Titan Medical President and CEO Cary Vance said he knew what he was getting into when he was approached about leading the robotic surgery company.

“The challenges, I knew what they were,” said Vance, who had served on the company’s board for two years when he became CEO of Titan in July. “I knew the opportunity we had to meet those challenges and knew the people I’d be working with … could make sure whatever strategy we have is executed.”

Vance sees “a unique opportunity” ahead of Toronto-based Titan, which is manufacturing the Enos surgical robot platform with plans to enter into clinical use next year.

In June, Titan delayed its FDA investigational device exemption (IDE) submission timeline for the roboti…

Read more
  • 0

Smith+Nephew announces first clinical use of Legion revision knee handheld robotics tech

The Cori surgical robot system for knee replacement. [Image from Smith+Nephew]Smith+Nephew (NYSE:SNN) today announced the first cases for revision knee replacement using the Cori surgical robot system.

Dr. Thorsten Seyler of Duke University performed the first cases on Aug. 17, 2022. Seyler used the combination of Smith+Nephew’s handheld Cori robotic technology with the Legion revision knee system. The system uses image-free smart mapping to eliminate the need for pre-operative CT/MRI scans. It also eliminates the potential for image distortion due to in situ components from the primary procedure.

London-based Smith+Nephew said in a news release that surgeons can build patient-specific 3D models of the joint. They can also register anatomy and bony defects after implant extraction. With the system, surgeons can intra-operatively gap balance in real-time, and accurately precision mill for final placement of components.

Smith+Nephew said it is the first…

Read more
  • 0